Literature DB >> 23211536

Alpha-fetoprotein receptor as an early indicator of HBx-driven hepatocarcinogenesis and its applications in tracing cancer cell metastasis.

Mengsen Li1, Mingyue Zhu, Wei Li, Yan Lu, Xieju Xie, Yuqiang Wu, Shaojiang Zheng.   

Abstract

AFP and its receptor (AFPR) are early indicators of HBx-driven hepatocarcinogenesis. Clinical specimens, normal human liver cells L-02 and HCC cell lines were selected for analyzing the effects of HBx on expression of AFP, AFPR, Src, CXCR4, and Ras. Results showed that AFPR localized in the membranes of HCC samples. HBx upregulated the expression of AFPR and AFP prior to expression of Src, CXCR4, and Ras in L-02 cells and in liver specimens; Target-labeled AFPR was able to reveal the location and metastatic status of HCC in vivo. In this way, actuated expression of AFPR served as an indicator suitable for use in the early diagnosis of HBx-driven malignant transformation of hepatocytes. Labeled AFPR may be applied to trace primary and metastatic HCC.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23211536     DOI: 10.1016/j.canlet.2012.11.042

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

1.  Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.

Authors:  Ya-Jun Ren; Tao Huang; Hong-Lu Yu; Li Zhang; Qian-Jin He; Zhi-Fan Xiong; Hua Peng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-12-07

2.  Alpha-fetoprotein activates AKT/mTOR signaling to promote CXCR4 expression and migration of hepatoma cells.

Authors:  Mingyue Zhu; Junli Guo; Hua Xia; Wei Li; Yan Lu; Xu Dong; Yi Chen; Xieju Xie; Shigan Fu; Mengsen Li
Journal:  Oncoscience       Date:  2015-01-06

3.  Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells.

Authors:  Mingyue Zhu; Junli Guo; Wei Li; Yan Lu; Shigan Fu; Xieju Xie; Hua Xia; Xu Dong; Yi Chen; Ming Quan; Shaojiang Zheng; Keping Xie; Mengsen Li
Journal:  Oncotarget       Date:  2015-05-20

4.  HBx induced AFP receptor expressed to activate PI3K/AKT signal to promote expression of Src in liver cells and hepatoma cells.

Authors:  Mingyue Zhu; Junli Guo; Wei Li; Hua Xia; Yan Lu; Xu Dong; Yi Chen; Xieju Xie; Shigan Fu; Mengsen Li
Journal:  BMC Cancer       Date:  2015-05-06       Impact factor: 4.430

5.  Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells.

Authors:  Yan Lu; Mingyue Zhu; Wei Li; Bo Lin; Xu Dong; Yi Chen; Xieju Xie; Junli Guo; Mengsen Li
Journal:  J Cell Mol Med       Date:  2016-01-12       Impact factor: 5.310

6.  Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.

Authors:  Mingjie Yao; Jingmin Zhao; Fengmin Lu
Journal:  Oncotarget       Date:  2016-01-26

7.  Expression and bioactivity of human α-fetoprotein in a Bac-to-Bac system.

Authors:  Bo Lin; Kun Liu; Wenting Wang; Wei Li; Xu Dong; Yi Chen; Yan Lu; Junli Guo; Mingyue Zhu; Mengsen Li
Journal:  Biosci Rep       Date:  2017-01-17       Impact factor: 3.840

8.  Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database.

Authors:  Nan Zhang; Jiajia Gu; Li Yin; Jing Wu; Ming-Yu Du; Kai Ding; Teng Huang; Xia He
Journal:  Oncotarget       Date:  2016-12-06

9.  Alpha fetoprotein antagonises benzyl isothiocyanate inhibition of the malignant behaviors of hepatocellular carcinoma cells.

Authors:  Mingyue Zhu; Wei Li; Junli Guo; Yan Lu; Xu Dong; Bo Lin; Yi Chen; Xueer Zhang; Mengsen Li
Journal:  Oncotarget       Date:  2016-11-15

10.  Hepatitis B Virus X Protein Driven Alpha Fetoprotein Expression to Promote Malignant Behaviors of Normal Liver Cells and Hepatoma Cells.

Authors:  Mingyue Zhu; Yan Lu; Wei Li; Junli Guo; Xu Dong; Bo Lin; Yi Chen; Xieju Xie; Mengsen Li
Journal:  J Cancer       Date:  2016-05-12       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.